Clinical Trial Update: Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma [Phase 2]

View source ↗

Summary

Completed Phase 2 trial evaluating the combination of capecitabine and thalidomide in previously treated metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Thalidomide (thalidomide)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Colorectal Adenocarcinoma | Phase 2 | Status: COMPLETED